COMPANY
Galderma
FDA-approved therapeutic company
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Global Medical Information Manager | Mumbai | Oct 23, 2026 | Oct 20, 2026 |
| Senior Financial Analyst | London | Oct 23, 2026 | Oct 23, 2026 |
| Quality Control Analyst | Uppsala | Oct 23, 2026 | Oct 23, 2026 |
| Product Operations Program Manager | 2 locations (listed on the posting) | Oct 23, 2026 | Oct 23, 2026 |
| Business Development Manager, Injectable Aesthetics | Location not stated | Oct 23, 2026 | Oct 23, 2026 |
Trial and FDA signals
- New trial + clinical hiring Started a Phase 3 trial (NCT07762833, actual start Oct 8, 2026); 11 clinical-operations roles open. ClinicalTrials.gov NCT07762833 (Oct 8, 2026)
Evidence (1 event)
- Oct 8, 2026 · ClinicalTrials.gov NCT07762833
leadSponsor.name='Galderma R&D'; phases=['PHASE3']; overallStatus=RECRUITING; startDateStruct={date:2026-10-08,type:ACTUAL}; studyFirstPostDate=2026-08-13; briefTitle='Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis'
- Oct 8, 2026 · ClinicalTrials.gov NCT07762833
Timeline
Open jobs 369
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Global Medical Information Manager | Mumbai | Oct 23, 2026 | Oct 20, 2026 | Not stated |
| Senior Financial Analyst | London | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Quality Control Analyst | Uppsala | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Product Operations Program Manager | 2 locations (listed on the posting) | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Business Development Manager, Injectable Aesthetics | Not listed | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Sales Coordinator | Not listed | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Tele Sales Ax | Frankfurt | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Consumer Key Account Manager - Pharmacy | North Sydney | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Key Account Manager, Dermatological Skincare | Petaling Jaya | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Medical Sales Representative | Makati | Oct 23, 2026 | Oct 23, 2026 | Not stated |
| Analyst, Workforce Analytics | 2 locations (listed on the posting) | Oct 22, 2026 | Oct 9, 2026 | Senior |
| Senior Scientific Writer | Mumbai | Oct 22, 2026 | Oct 17, 2026 | Not stated |
| Head Scientific Medical Services Hub | Mumbai | Oct 22, 2026 | Oct 20, 2026 | Not stated |
| Aide-Opérateur - Jour | 2 locations (listed on the posting) | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Associate Director, Commercial Strategy and Operations | 3 locations (listed on the posting) | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Aide-Opérateur Nuit | 2 locations (listed on the posting) | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Aesthetic Business Manager - Atlanta Northwest | Atlanta | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Opérateur de Production Conditionnement Nuit | 2 locations (listed on the posting) | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Opérateur de Production Conditionnement Soir | 2 locations (listed on the posting) | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Automation Engineer | Uppsala | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Key Account Manager – Chain Pharmacy | Mumbai | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Senior Sales Representative, Injectable Aesthetics | Beijing | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Sales Manager (Pharmacy Channel) | Petaling Jaya | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Key Account Manager, RX | Singapore | Oct 21, 2026 | Oct 9, 2026 | Mid |
| Opérateur entrepôt - FDS Nuit | Baie-D'Urfé | Oct 21, 2026 | Oct 9, 2026 | Mid |
| Account Manager, Immunology - White Plains, NY | White Plains, NY | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Account Manager, Immunology - Long Beach, CA | Long Beach | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Aesthetic Business Manager- Houston Northeast | Houston | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Mécanicien de machines fixes | Baie-D'Urfé | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Account Manager, Immunology - Walnut Creek, CA | Walnut Creek, CA | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Underhållstekniker, Galderma | Uppsala | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Ethical Brand Manager, Dermatological Skincare | Ho Chi Minh City | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Senior Account Representative | Hong Kong | Oct 21, 2026 | Oct 23, 2026 | Not stated |
| Sales Execution & Activation Executive | North Sydney | Oct 20, 2026 | Oct 14, 2026 | Not stated |
| Senior Sales Representative, Injectable Aesthetics | Shanghai | Oct 20, 2026 | Oct 20, 2026 | Not stated |
| Account Manager, Immunology - Los Angeles / Burbank, CA | 3 locations (listed on the posting) | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Field Access Manager, Southeast - Raleigh, NC | Raleigh | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Representante de ventas Consumo - Monterrey | Mexico City | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Manager, U.S. Benefits | Boston | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Senior Employee Relations Partner | Remote-US | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Account Manager, Immunology - Asheville, NC | Asheville, NC | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Invoicing & Receivables Coord | Mexico City | Oct 20, 2026 | Oct 23, 2026 | Not stated |
| Medical Representative - Dermatological Skincare, Pharmacies (Riyadh) | Riyadh | Oct 19, 2026 | Oct 9, 2026 | Mid |
| Director, Head of Global Nemluvio Regulatory Strategy | Boston | Oct 19, 2026 | Oct 9, 2026 | Executive |
| Senior Demand Planner - Consumer | Miami | Oct 19, 2026 | Oct 9, 2026 | Senior |
| Global Head of Therapeutic Dermatology Regulatory Strategy | Boston | Oct 19, 2026 | Oct 9, 2026 | Executive |
| Customer Education and Training Specialist, Injectable Aesthetics | Jakarta | Oct 19, 2026 | Oct 14, 2026 | Not stated |
| Sales Coordinator - Aesthetics | Warszawa | Oct 19, 2026 | Oct 20, 2026 | Not stated |
| Marketing Lead - Prescription | Stockholm | Oct 19, 2026 | Oct 20, 2026 | Not stated |
| Opérateur Entrepôt Cariste - Soir | Baie-D'Urfé | Oct 19, 2026 | Oct 20, 2026 | Not stated |
FDA records (last 2 years)
- FDA Original approval: NEMLUVIO (nemolizumab-ilto) — BLA761391, Dec 13, 2024. Applicant at approval: Galderma Laboratories, LP. source ↗
Connect
See your connections at Galderma on LinkedIn (search by name, results not checked)